Literature DB >> 2181492

Metabolism of drugs and other xenobiotics in the gut lumen and wall.

K F Ilett1, L B Tee, P T Reeves, R F Minchin.   

Abstract

Metabolism in the gut lumen and wall can decrease the bioavailability and the pharmacological effects of a wide variety of drugs. Bacterial flora in the gut, the environmental pH and oxidative or conjugative enzymes present in the intestinal epithelial cells can all contribute to the process. Bacterial biotransformation is greatest in the colon, while gut wall metabolism is generally highest in the jejunum and decreases distally. Gut wall metabolism may be induced or inhibited by dietary or environmental xenobiotics or by co-administered drugs. Recent evidence suggests that some drugs, food-derived mutagens and other xenobiotics can be metabolized by gut flora and/or gut wall enzymes to reactive species which may cause tumors.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2181492     DOI: 10.1016/0163-7258(90)90036-2

Source DB:  PubMed          Journal:  Pharmacol Ther        ISSN: 0163-7258            Impact factor:   12.310


  38 in total

Review 1.  The mucosa of the small intestine: how clinically relevant as an organ of drug metabolism?

Authors:  Margaret M Doherty; William N Charman
Journal:  Clin Pharmacokinet       Date:  2002       Impact factor: 6.447

Review 2.  Enterohepatic circulation: physiological, pharmacokinetic and clinical implications.

Authors:  Michael S Roberts; Beatrice M Magnusson; Frank J Burczynski; Michael Weiss
Journal:  Clin Pharmacokinet       Date:  2002       Impact factor: 6.447

Review 3.  Efflux transporters as a novel herbivore countermechanism to plant chemical defenses.

Authors:  Jennifer S Sorensen; M Denise Dearing
Journal:  J Chem Ecol       Date:  2006-05-23       Impact factor: 2.626

4.  Selecting a medical therapy for overactive bladder.

Authors:  H Henry Lai; Timothy B Boone; Rodney A Appell
Journal:  Rev Urol       Date:  2002

Review 5.  The conduct of drug metabolism studies considered good practice (I): analytical systems and in vivo studies.

Authors:  Xiaodong Liu; Lee Jia
Journal:  Curr Drug Metab       Date:  2007-12       Impact factor: 3.731

6.  Loss of orally administered drugs in GI tract.

Authors:  Yogeshkumar Nanasaheb Gavhane; Adhikrao Vyankatrao Yadav
Journal:  Saudi Pharm J       Date:  2012-04-20       Impact factor: 4.330

7.  Characterization of the contents of ascending colon to which drugs are exposed after oral administration to healthy adults.

Authors:  Amalia Diakidou; Maria Vertzoni; Konstantinos Goumas; Erik Söderlind; Bertil Abrahamsson; Jennifer Dressman; Christos Reppas
Journal:  Pharm Res       Date:  2009-07-02       Impact factor: 4.200

8.  Stability of UC-781, in intestinal mucosal homogenates of the rat, rabbit, and pig.

Authors:  G Van den Mooter; G Stas; F Damian; L Naesens; J Balzarini; R Kinget; P Augustijns
Journal:  Pharm Res       Date:  1998-11       Impact factor: 4.200

Review 9.  Human colonocyte detoxification.

Authors:  W E Roediger; W Babidge
Journal:  Gut       Date:  1997-12       Impact factor: 23.059

10.  Metabolism of diltiazem in hepatic and extrahepatic tissues of rabbits: in vitro studies.

Authors:  W Homsy; M Lefebvre; G Caillé; P du Souich
Journal:  Pharm Res       Date:  1995-04       Impact factor: 4.200

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.